Trial intelligence / Profile preview

Propofol versus remimazolam anesthesia for sleep quality after ambulatory gastroenteroscopic polypectomy

ChiCTR2300075086Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in gastrointestinal polyp comparing Propofol Group with Remimazolam Group (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index at 24 hours postoperatively. Planned start Aug 2023; status: not yet recruiting.

02

Drugs

propofolremimazolam
03

Conditions

gastrointestinal polyp

Beyond the preview

Go deeper on ChiCTR2300075086.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075086.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call